SPEVIGO 150 mg, solution for injection in a pre-filled syringe 2 syringes of 1 ml
Active ingredients: SPÉSOLIMAB
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injection2 syringes of 1 mlsous-cutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- SPEVIGO 150 mg, solution injectable en seringue préremplie
- Pharmaceutical form
- solution injectable
- Route of administration
- sous-cutanée
- Presentation description
- 2 seringues préremplies en verre de 1 mL
- Marketing authorisation holder
- LEO PHARMA A/S (DANEMARK)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 8 Jan 2025
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Initial prescription by a hospital doctor
- Prescribed by specialists only
- Enhanced ANSM monitoring
- Yes
BDPM identifiers
CIS
60808470CIP73030221CIP133400930302217Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| SPÉSOLIMABsolution | 150 mg · une seringue préremplie de 1 mL | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.